EMYRIA LIMITED — Director's Dealing 2023

Feb 22, 2023

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.s

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and made be made public.

Introduced 30/09/2001

Introduced 30/09/2001
Name of entity:	Emyria Limited
ABN:	625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

director for the purposes	of section 205G of the Corporations Act.
Name of Director:	Stewart Washer
Date of last notice:	16 November 2020

Part 1 - Change of director’s relevant interests in securities

Note: In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Dr Stewart James Washer & Dr Patrizia Derna Washer Fund> (Dr Washer is a trustee and beneficiary of the superannuation fund) Dr Stewart James Washer & Dr Patrizia Derna Washer (Dr Washer is a trustee and beneficiary of the Trust) Mal Washer Nominees Pty Ltd Family A/C> (Dr Washer is a trustee and beneficiary of the trust)
Date of change	23 February 2023
No. of securities held prior to change
Dr Stewart James Washer & Dr Patrizia Derna Washer Fund> (Dr Washer is a trustee and beneficiary of the superannuation fund) Dr Stewart James Washer & Dr Patrizia Derna Washer (Dr Washer is a trustee and beneficiary of the Trust) Mal Washer Nominees Pty Ltd Family A/C> (Dr Washer is a trustee and beneficiary of the trust)	1,325,599 Ordinary Shares 28,400,000 Ordinary Shares 1,500,000 Unlisted Options exercisable at $0.45 expiring 13 June 2023 19,600,000 Ordinary Shares

• See chapter 19 for defined terms

Appendix 3Y pg. 1

Appendix 3Y Change of Director’s Interest Notice

	Appendix 3Y Change of Director’s Interest Notice
Class changed	Ordinary Shares Unlisted Options
Number acquired	333,333 Ordinary Shares 166,667 Unlisted Optionsexercisable at $0.35 on or before 22 November 2025
Number disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.18 per Ordinary Share $0.00 per Ordinary Option
No. of securities held after change
Dr Stewart James Washer & Dr Patrizia Derna Washer Fund> (Dr Washer is a trustee and beneficiary of the superannuation fund) Dr Stewart James Washer & Dr Patrizia Derna Washer (Dr Washer is a trustee and beneficiary of the Trust) Mal Washer Nominees Pty Ltd Family A/C> (Dr Washer is a trustee and beneficiary of the trust)	1,325,599 Ordinary Shares 28,400,000 Ordinary Shares 1,500,000 Unlisted Options exercisable at $0.45 expiring 13 June 2023 19,933,333 Ordinary Shares 166,667 Unlisted OptionsUnlisted Options exercisable at $0.35 on or before 22 November 2025
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of placement securities following shareholder approval at General Meeting

Part 2 - Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

disclosed in this part.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: if consideration is non-cash, provide details and an estimated valuation	N/A

• See chapter 19 for defined terms

Appendix 3Y pg. 2

Appendix 3Y Change of Director’s Interest Notice

		Appendix 3Y Change of Director’s Interest Notice
Interest after changes		N/A
Part 3 – Closed Period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	Yes
If so, was prior written clearance provided to allow the trade to proceed during this period?	Yes
If prior written clearance was provided, on what date was this provided?	20/02/2023 On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended.

• See chapter 19 for defined terms

Appendix 3Y pg. 3

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Emyria Limited ACN 625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Michael Winlo
Date of last notice	28 November 2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Michael Gordon Winlo (Michael Winlo is trustee and a beneficiary of this trust)
Date of change	23 February 2023
No. of securities held prior to change	Michael Gordon Winlo 60,000 Ordinary Shares Michael Gordon Winlo 3,500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 4,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 3,000,000 Unlisted Options exercisable at $0.296 on or before 23 November 2026
Class	Ordinary Shares Unlisted Options
Number acquired	222,222 Ordinary Shares 111,111 Unlisted Options exercisable at $0.35 on or before 22 November 2025
Number disposed	-

Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.18 Per Ordinary Share $0.00 per attaching Option
No. of securities held after change	Michael Gordon Winlo 282,222 Ordinary Shares 111,111 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Michael Gordon Winlo 3,500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 4,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 3,000,000 Unlisted Options exercisable at $0.296 on or before 23 November 2026
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of placement securities following shareholder approval at General Meeting

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	Yes
If so, was prior written clearance provided to allow the trade to proceed during this period?	Yes

	If prior written clearance was provided, on what date was this provided?	20/02/2023 On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended.

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.s

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and made be made public.

Introduced 30/09/2001

Introduced 30/09/2001
Name of entity:	Emyria Limited
ABN:	625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

director for the purposes	of section 205G of the Corporations Act.
Name of Director:	Alistair Vickery
Date of last notice:	16 November 2020

Part 1 - Change of director’s relevant interests in securities

Note: In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Netwealth Investments Limited Dr Vickery is a member of a managed superannuation fund Cherylyn Vickery Dr Vickery is a beneficiary of this trust>
Date of change	23 February 2023
No. of securities held prior to change
Alistair Vickery	Netwealth Investments Limited 128,000 Ordinary Shares Alistair Vickery 2,000,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 Cherylyn Vickery 2,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024
Class changed	Ordinary Shares Unlisted Options
Number acquired	138,889 Ordinary shares 69,444 Unlisted Options exercisable at $0.35 on or before 22 November 2025

• See chapter 19 for defined terms

Appendix 3Y pg. 1

Appendix 3Y Change of Director’s Interest Notice

	Appendix 3Y Change of Director’s Interest Notice
Number disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.18 per Ordinary Share $0.00 per attaching Option
No. of securities held after change
	Netwealth Investments Limited 128,000 Ordinary Shares Alistair Vickery 138,889 Ordinary Shares 2,000,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 69,444 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Cherylyn Vickery 2,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of placement securities following shareholder approval at General Meeting

Part 2 - Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

disclosed in this part.
Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: if consideration is non-cash, provide details and an estimated valuation	N/A
Interest after changes	N/A

Part 3 – Closed Period

Were the interests in the securities or contracts Yes detailed above traded during a +closed period where prior written clearance was required?

• See chapter 19 for defined terms

Appendix 3Y pg. 2

Appendix 3Y Change of Director’s Interest Notice

	Appendix 3Y Change of Director’s Interest Notice
If so, was prior written clearance provided to allow the trade to proceed during this period?	Yes
If prior written clearance was provided, on what date was this provided?	20/02/2023 On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended.

• See chapter 19 for defined terms

Appendix 3Y pg. 3

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Emyria Limited ACN 625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Mr Matthew Callahan
Date of last notice	16 November 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Mercator Shipwrights Pty Ltd (Mr Callahan is a beneficiary of this Trust) Shenasaby Pty Ltd < Shenasaby Trust> (Mr Callahan is a beneficiary of this trust)
Date of change	23 February 2023
No. of securities held prior to change	Mercator Shipwrights Pty Ltd 19,600,000 Ordinary Shares Shenasaby Pty Ltd < Shenasaby Trust> 1,500,000 Unlisted options exercisable at $0.114 on or before 13 November 2024
Class	Ordinary Shares Unlisted Options
Number acquired	55,556 Ordinary Shares 27,778 Unlisted Options exercisable at $0.35 on or before 22 November 2025
Number disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.18 per Ordinary Share $0.00 per attaching Option

No. of securities held after change	Mercator Shipwrights Pty Ltd 19,655,556 Ordinary Shares 27,778 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Shenasaby Pty Ltd < Shenasaby Trust> 1,500,000 Unlisted options exercisable at $0.114 on or before 13 November 2024
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of placement securities following shareholder approval at General Meeting

Part 2 – Change of director’s interests in contracts – N/A

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	Yes
If so, was prior written clearance provided to allow the trade to proceed during this period?	Yes

	If prior written clearance was provided, on what date was this provided?	20/02/2023 On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended.

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Emyria Limited ACN 625 085 734

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Karen Smith
Date of last notice	7 December 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.
Date of change	23 February 2023
No. of securities held prior to change	550,000 Ordinary Shares 1,500,000 Unlisted options exercisable at $0.268 expiring on 22/2/2024
Class	Ordinary Shares Unlisted Options
Number acquired	83,333 Ordinary Shares 41,667 Unlisted Options Unlisted Options exercisable at $0.35 on or before 22 November 2025
Number disposed	-
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	$0.18 per Ordinary Share $0.00 per attaching Option

No. of securities held after change	633,333 Ordinary Shares 1,500,000 Unlisted options exercisable at $0.268 expiring on 22/2/2024 41,667 Unlisted Options exercisable at $0.35 on or before 22 November 2025
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Issue of placement securities following shareholder approval at General Meeting

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	Yes
If so, was prior written clearance provided to allow the trade to proceed during this period?	Yes

	If prior written clearance was provided, on what date was this provided?	20/02/2023 On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended.